These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 4858188)

  • 1. [Effect of L-dopa on TSH secretion mechanism in the course of treatment for hyperthyroidism].
    Nakamura Y; Kobayashi I; Tonooka N; Tsuyusaki K; Shimomura Y
    Horumon To Rinsho; 1974 Mar; 22(3):403-8. PubMed ID: 4858188
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of L-dopa on pituitary TSH and GH secretion in Parkinson's disease].
    Sakoda M; Kusaka T; Baba S; Shirakata S
    Nihon Naibunpi Gakkai Zasshi; 1972 Jul; 48(4):241-4. PubMed ID: 5066290
    [No Abstract]   [Full Text] [Related]  

  • 3. L-DOPA suppression of thyrotropin-releasing hormone response in man.
    Spaulding SW; Burrow GN; Donabedian R; van Woert M
    J Clin Endocrinol Metab; 1972 Jul; 35(1):182-5. PubMed ID: 4624348
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional evaluation of prolactin secretion: a guide to therapy.
    Friesen H; Guyda H; Hwang P; Tyson JE; Barbeau A
    J Clin Invest; 1972 Mar; 51(3):706-9. PubMed ID: 4622109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of oral administration of L-dopa on plasma levels of TSH, ACTH and GH in normal subjects].
    Simonin R; Roux H; Oliver C; Jaquet P; Argemi B; Vague P
    Sem Hop; 1973 Feb; 49(9):617-21. PubMed ID: 4350369
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of inappropriate TSH secretion with Triac].
    Lind P; Eber O
    Acta Med Austriaca; 1986; 13(1):13-6. PubMed ID: 3766083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study.
    Rosario PW
    Clin Endocrinol (Oxf); 2010 May; 72(5):685-8. PubMed ID: 20447066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of inappropriate non-neoplastic secretion of TSH treated with bromocriptine.
    Yeğen C; Aktan AO; Saraç AM; Yalin R
    Endocr Regul; 1993 Mar; 27(1):23-5. PubMed ID: 8003703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative studies on the behavior of thyroid hormone levels and TSH level in the TRH-test in the course of experimental and thyreostatically treated hyperthyroidism].
    Hartmann KP; Henderkott U; Hör G; Bottermann P
    Verh Dtsch Ges Inn Med; 1975; 81():1559-63. PubMed ID: 58496
    [No Abstract]   [Full Text] [Related]  

  • 10. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
    Hubalewska-Hola A; Fröss K; Kostecka-Matyja M; Sowa-Staszczak A; Szybiński Z; Huszno B; Ptak M
    Przegl Lek; 2003; 60(11):768-71. PubMed ID: 15058054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of TSH suppression using a 3d-generation TSH assay: diagnostic and therapeutic consequences].
    Exer P; Staub JJ; Zulewski H; Müller B; Kunz M; Huber P
    Schweiz Med Wochenschr; 1992 Dec; 122(51-52):1964-7. PubMed ID: 1475661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthyroidism due to inappropriate secretion of thyroid-stimulating hormone: diagnosis and management.
    Hermus A; Ross H; van Liessum P; Naber A; Smals A; Kloppenborg P
    Neth J Med; 1991 Jun; 38(5-6):193-8. PubMed ID: 1922591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthyroidism, inappropriate plasma TSH and pituitary adenoma in three patients, two receiving long-term phenothiazine therapy.
    Dunne FP; Feely MP; Ferriss JB; Keohane C; Murphy D; Perry I
    Q J Med; 1990 Apr; 75(276):345-54. PubMed ID: 2117296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".
    Gershengorn MC; Weintraub BD
    J Clin Invest; 1975 Sep; 56(3):633-42. PubMed ID: 1159077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin-releasing hormone.
    Pittman JA
    Adv Intern Med; 1974; 19():303-25. PubMed ID: 4205606
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism.
    Das G; Ojewuyi TA; Baglioni P; Geen J; Premawardhana LD; Okosieme OE
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):146-51. PubMed ID: 22283624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
    Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
    Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism.
    Sawin CT; Geller A; Kaplan MM; Bacharach P; Wilson PW; Hershman JM
    Arch Intern Med; 1991 Jan; 151(1):165-8. PubMed ID: 1985591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of serum angiotensin converting enzyme in hyperthyroidism correlated to that of TSH].
    Letizia C; Sellini M; Baccarini S; Scavo D
    Minerva Med; 1991 Jun; 82(6):333-7. PubMed ID: 1712434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.